Nancy M. Hardy, M.D.
Experimental Transplantation and Immunology Branch
National Cancer Institute
10 Center Drive
Bethesda, MD 20892
Dr. Hardy received her M.D. from the University of Washington in 1995. She completed clinical training in internal medicine at Duke University Medical Center in 1998 and fellowships in hematology and oncology at Duke University Medical Center and in infectious diseases at the National Institute of Allergy and Infectious Diseases in 2002. From 2000 to 2003, Dr. Hardy trained in cellular immunology in the laboratory of Dr. Ronald Gress in the Experimental Immunology Branch. Using murine models, her research foci included study of the chemokine system in thymopoiesis and recovery of T-lymphopenia and examination of sites and mechanisms of extrathymic T-cell ontogeny in the context of severe T-lymphopenia. She was awarded a senior fellowship in transplantation in the CCR’s Experimental Transplantation and Immunology Branch in 2003 and joined the senior clinical faculty in 2005. Dr. Hardy currently serves as head for the Prevention and Treatment of Cancer Relapse Section, which is committed to developing interventions based on an emerging understanding of the immunologic bases of graft-versus-tumor.
Dr. Hardy's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trials for patients with hematological/blood cancer. Click on the trial below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.